Action-effect Anticipation in Patients With Parkinson's Disease : A Study of the Sensory Attenuation Marker.
- Conditions
- Parkinson Disease
- Interventions
- Behavioral: behavioral observation
- Registration Number
- NCT02894333
- Lead Sponsor
- Fondation Ophtalmologique Adolphe de Rothschild
- Brief Summary
The ideomotor theory of action control is considered to be central to the understanding of human voluntary action. According to the ideomotor theory, an action is represented in terms of its desired sensory effects and actions are selected by internally activating these effect representations. Recent imagery and behavioral studies showed that this anticipated representation of action-effects triggered a "sensory attenuation", meaning a decrease of perceptive performances or a decrease of sensory event-related potentials (ERP) for an expected event. Thus, the sensory attenuation constitutes a relevant behavioral tool to investigate sensory anticipation impairment in patients with Parkinson's disease. In a behavioral paradigm, patients and matched control participants have to perform a perceptive task on predicted visual action-effects mixed with mispredicted visual action effects. Performances should be better in mispredicted visual action effects for control participants only.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- All
- Target Recruitment
- 1
- Parkinson's disease
- Normal or corrected vision
- Other pathology or neurological or psychiatric history
- Known pregnancy or breastfeeding
- Absence of affiliation to the French Social Security
- Person under legal protection
- Patient's opposition to participate
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Patients with Parkinson's disease behavioral observation -
- Primary Outcome Measures
Name Time Method median score baseline scores measured with the Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS)
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (2)
Fondation Adolphe de Rothschild
🇫🇷Paris, France
Fondation Ophtalmologique Adolphe de Rothschild
🇫🇷Paris, France